I'm going to put "Is ciccio _||_ age an assumption?" on a t-shirt

Third takeaway: most other acquisitions seem to have no obvious effect on prices or coverage (caveat: drug prices move a lot, so it’s hard to detect these effects with precision)

Second takeaway: acquisitions that are not disclosed to the FTC are followed by massive increases in price, and large declines in formulary coverage (caveat: there are not that many of them!)

First takeaway: there is a lot of M&A! One third of all branded drugs are acquired prior to patent expiration. Most of them are acquired by companies that have NO other drug with a similar indication.

For a small fee, I will send a dramatic reading in a heavy Italian accent